Page 5 - Aspire Newsletter APRIL 2022 Vol 7 / Issue 2

COMPELLING CONGRESS PROGRAM
International focus on
advances in assisted
reproduction turns to
the Asia Pacific region
The ASPIRE 2022 Congress is now only days away in a virtual, but vital format that promises to project participants into exciting future developments in assisted reproductive technology.
With 30 concurrent sessions over three days from 29 April to 1 May, the Congress will feature 110 outstanding speakers as the global focus on advances in assisted reproduction turns to the Asia Pacific region.
Professor Budi Wiweko, Chairman of the Congress Scientific Committee, said participants would gain “cutting edge” knowledge about assisted reproductive technology that could be applied to improve the quality of patient care and treatment outcomes in their clinics.
The Congress program will cover basic reproductive sciences, embryology and clinical sessions.
It will explore the impacts of the COVID-19 pandemic on IVF treatment cycles, latest global data on outcomes of assisted reproductive technology, fertility preservation in cancer patients, the future of miscarriage care and challenges of access to and affordability of infertility treatment.
There will also be a special educational video presentation on complicated reproductive surgery, a focus on artificial intelligence, robotics and digital advances along with compelling panel sessions to discuss perspectives on new or controversial topics.
The subject of the highly anticipated Bruno Lunenfeld Lecture on day one of the Congress will be Global ART Data: What Does It Tell Us About Our World? It will be delivered by acclaimed American reproductive endocrinologist and surgeon, David Adamson, Clinical Professor at Stanford University School of Medicine, Past President of the American Society for Reproductive Medicine,
Chair of the International Committee Monitoring ART (ICMART) and President of the World Endometriosis Research Foundation.
There will be seven keynote lectures as follows:
• Fertility Preservation in Patients with Cancer by Professor Marie-Madeleine Dolmans, Head of the Gynaecology Research Laboratory at the Université Catholique de Louvain in Brussels and President of the International Society for Fertility Preservation;
• The Sixth Vital Sign: What Sperm Are Trying to Tell Us – Associate Professor Michael Eisenberg, Director of Male Reproductive Medicine and Surgery at Stanford University School of Medicine;
• Key Regulators in Embryo Implantation: Lessons From Mice – Associate Professor Yasushi Hirota, Department of Obstetrics and Gynaecology, The University of Tokyo;
• Future Development of In Vitro Growth and In Vitro Culture of Follicles – Professor Evelyn Telfer, Institute of Cell Biology at the University of Edinburgh;
• Endometriosis Is A Chronic Systemic Disease – Hugh Taylor, Professor of Molecular, Cellular and Developmental Biology at Yale University and President of the American Society for Reproductive Medicine;
• Androgens Across the Life Span of Women: What Is Their Importance? – Professor Susan Davis, Director of Monash University Women’s Health Research Program in Melbourne and Past President of the International Menopause Society, and
• The Future of Miscarriage Care – Professor Siobhan Quenby, Director of the Biomedical Research Unit in Reproductive Health and Professor of Obstetrics at the University of Warwick in the United Kingdom.
Among other highlights will be Pre-Congress Courses on male infertility, embryology, reproductive surgery, endometriosis, reproductive endocrinology and endometrium and implantation.
To register for the Congress or Pre-Congress Courses go to the website http://www.aspire-2022. com/registration/
For more information go to www.aspire-2022.com
3